Home / 2022 / November / 02 (page 2)

Daily Archives: November 2, 2022

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages U.S. Bancorp Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – USB

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of U.S. Bancorp (NYSE: USB) between August 1, 2019 and July 28, 2022, both dates inclusive (the “Class Period”). A class action […]

Read More »

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages International Game Technology PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – IGT

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of International Game Technology PLC (NYSE: IGT) between March 16, 2018 and August 29, 2022, both dates inclusive (the “Class Period”), of the important December 13, 2022 lead plaintiff deadline. SO WHAT: […]

Read More »

YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – YMAB

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you […]

Read More »

TIL EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Instil Bio, Inc. Investors to Inquire About Securities Class Action Investigation – TIL

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Instil Bio, Inc. (NASDAQ: TIL) resulting from allegations that Instil Bio may have issued materially misleading business information to the investing public. SO WHAT: If you […]

Read More »

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November 21, 2022 lead plaintiff deadline. SO WHAT: If […]

Read More »
Scroll To Top